The INK4a/ARF network in tumour suppression

Nature Reviews Molecular Cell Biology

Volumn 2, Issue 10, 2001, Pages 731-737

  Sherr, Charles J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; PROTEIN P16INK4A;

ANIMAL; BIOLOGICAL MODEL; HUMAN; NEOPLASM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ADP-RIBOSYLATION FACTOR 1; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENES, P53; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 0035487104     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35096061     Document Type: Review

References (77)

1. Weinberg, R. A. The retinoblastoma gene and cell cycle control. Cell 81, 323-330 (1995).
2. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262 (1998).
3. Serrano, M., Hannon, G. J. & Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707 (1993).
4. Sherr, C. J. Cancer cell cycles. Science 274, 1672-1677 (1996).
5. Levins, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
6. Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from diverging signals. Genes Dev. 12, 2973-2983 (1998).
7. Sionov, R. V. & Haupt, Y. The cellular response to p53: the decision between life and death. Oncogens 18, 6145-6157 (1999).
8. Bates, S. & Vousden, K. H. Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci. 55, 28-37 (1999).
9. Juven-Gershon, T. & Oren, M. Mdm2: the ups and downs. Mol. Med. 5, 71-83 (1999).
10. Zhang, Y. & Xiong, Y. Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ. 12, 175-186 (2001).
11. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell. Biol. 1, 20-26 (1999).
12. ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22-27 (1999).
13. ARF without relocation of MDM2 to the nucleolus. Nature Cell Biol. 3, 445-452 (2001).
14. Quelle, D. E., Zindy, F., Ashmun, R. A. & Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000 (1995).
15. Kamb, A. et al. A cell cycle regulator involved in genesis of many tumor types. Science 264, 436-440 (1994).
16. Ruas, M. & Peters, G. The p16'*«/CDKN2A tumor suppressor and its relatives. Biochem. Biophys. Acta Rev. Cancer 1378, F115-F177 (1998).
17. Nevins, J. R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9, 585-593 (1998).
18. Harbour, J. W. & Dean, D. C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409 (2000).
19. Roussel, M. F. The INK4 family of cell cycle inhibitors in cancer. Oncogene 18, 5311-5317 (1999).
20. INK4a-mediated growth suppression. Mol. Cell. Biol. 16, 1047-1057 (1996).
21. DeGregori, J., Leone, G., Miron, A., Jakoi, L. & Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl Acad. Sci. USA 94, 7245-7250 (1997).
22. Muller H. et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267-285 (2001).
23. Humbert, P. O. et al. E2f3 is critical for normal cellular proliferation. Genes Dev. 14, 690-703 (2000). Disruption of mouse E2f3, but not E2f1, reduces transcription of E2f-responsive genes and retards entry into S phase.
24. Ziebold, U., Reza, T., Caron, A. & Lees, J. A. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15, 386-391 (2001).
25. Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G. & Dowdy, S. F. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407, 642-645 (2000).
26. Irwin, M. et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645-648 (2000).
27. +/- mice. Nature Genet. 18, 360-364 (1998).
28. Pan, H. et al. Key roles for E2F1 in signaling p53-dependent apoptosis and cell division. Mol. Cell 2, 283-292 (1998).
29. Tsai, K. et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293-304 (1998).
30. Lipinski, M. M. & Jacks, T. The retinoblastoma gene family in differentiation and development. Oncogene 18, 7873-7882 (1999).
31. CDKN2A tumor suppressor. Nature 375, 503-506 (1995).
32. Koh, J., Enders, G. H., Dynlacht, B. D. & Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature 375, 506-510 (1995).
33. Ink4a requires functional retinoblastoma protein. Proc. Natl Acad. Sci. USA 92, 6289-6293 (1995).
34. 1-phase progression. Genes Dev. 13, 1501-1512 (1999).
35. INK4a) confers susceptibility to metastatic melanoma in mice. Nature 413, 83-86 (2001).
36. Ink4a instead reflect Arf function, Ink4a does function as a tumour-suppressor gene in the mouse.
37. INK4c cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19, 3496-3506 (2000).
38. INK4b. Cancer Res. 56, 722-727 (1996).
39. Ink4d. Mol. Cell. Biol. 21, 3244-3255 (2001).
40. Zindy, F. et al. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc. Natl Acad. Sci. USA 96, 13462-13467 (1999).
41. Franklin, D. S., Godfrey, V. L., O'Brien, D. A., Deng, C. & Xiong, Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol. Cell. Biol. 20, 6147-6158 (2000).
42. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37 (1996).
43. ARF. Cell 91, 649-659 (1997).
44. ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc. Natl Acad. Sci. USA 95, 2429-2434 (1998).
45. Eschen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J. & Cleveland, J. L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13, 2658-2669 (1999).
46. Jacobs, J. J. L. et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678-2690 (1999).
47. Schmitt, C. A., McCurrach, M. E., De Stanchina, E. & Lowe, S. W. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670-2677 (1999).
48. Camero, A., Hudson, J. D., Price, C. M. & Beach, D. H. p16INK4a and p19ARF act in overlapping pathways in cellular immortalization. Nature Cell Biol. 2, 148-155 (2000).
49. Chin, L. et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 11, 2822-2834 (1997).
50. Sherr, C. J. & DePinho, R. A. Cellular senescence: mitotic clock or culture shock. Cell 102, 407-410 (2001).
51. Wright, W. E. & Shay, J. W. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev. 11, 98-103 (2001).
52. 1 control and immortalization. Genes Dev. 14, 3037-3050 (2000).
53. 1 control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14, 3051-3064 (2000).
54. Arf.
55. Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages. Proc. Natl Acad. Sci. USA, 96, 9654-9659 (2001). Like MEFs, mouse bone-marrow-derived pre-B cells that lack Arf are immortal, whereas bone-marrow-derived macrophages must also silence the Ink4a gene to become established as continuously growing cell lines.
56. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88 (1998).
57. Brenner, A. J., Stampfer, M. R. & Aldaz, C. M. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 17, 199-205 (1998).
58. Ink4a and enable their immortalization by introducing the telomerase catalytic subunit
59. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433 (1998).
60. ARF tumor suppressor. Genes Dev. 12, 2434-2442 (1998).
61. ARF links the tumor suppressor p53 to ras. Nature 395, 125-126 (1998).
62. Arf Induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation. Proc. Natl Acad. Sci. USA 95, 13194-13199 (1998).
63. INK4a. Cell 88, 593-602 (1997).
64. ARF. Cell 103, 321-330 (2000). Although Ras triggers Arf induction and thereby antagonizes Mdm2, Ras-dependent signalling through an Arf-independent pathway can lead to Mdm2 induction. In the absence of Arf, the latter pathway should dominate, making cells resistant to p53 induction following DNA damage.
65. ARF links the tumour suppressors RB and p53. Nature 395, 124-125 (1998).
66. Leone, G. et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8, 105-113 (2001).
67. ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion. Proc. Natl Acad. Sci. USA 97, 3266-3271 (2000). DNA damage activates p53 through both Arf-independent and Arf-dependent signalling pathways, so Arf loss affects the durability of the DNA-damage response.
68. Kastan, M. B. & Lim, D. The many substrates and functions of ATM. Nature Rev. Mol. Cell Biol. 1, 179-186 (2000).
69. Maya, R. et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role of p53 activation by DNA damage. Genes Dev. 15, 1067-1077 (2001).
70. Lin, W.-C., Lin, F.-T. & Nevins, J. R. Selective induction of E2F1 in response to DNA damage mediated by ATM-dependent phosphorylation. Genes Dev. 15, 1833-1844 (2001). The Atm kinase phosphorylates E2f1, enhancing its activity. This indicates a novel mechanism by which ATM might induce p53.
71. Jacobs, J. J., Kieboorn, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168 (1999).
72. Maestro, R. et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13, 2207-2217 (1999).
73. Jacobs, J. J. L et al. Senescence bypass screen identified TBX2, which represses cdkn2a (p19ARF) and is amplified in a subset of human breast cancers. Nature Genet. 26, 291-299 (2000).
74. Pantoja, C. & Serrano, M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 18, 4974-4982 (1999).
75. Kamijo, T. et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292-8297 (1998).
76. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBOJ. 17, 5001-5014 (1998).
77. Arf into primary MEFs that lack Arf, Mdm2 and p53 induces G1 arrest, albeit slowly. Arf must interact with proteins other than Mdm2.